(Q40383852)

20 September 2017

title

Detection, epitope-mapping and function of anti-Fas autoantibody in patients with silicosis (English)

1 reference

20 September 2017

1 reference

Akiko Takata-Tomokuni

1

1 reference

20 September 2017

Ayako Ueki

2

1 reference

20 September 2017

Mieko Shiwa

3

1 reference

20 September 2017

Yumika Isozaki

4

1 reference

20 September 2017

Tamayo Hatayama

5

1 reference

20 September 2017

Hironobu Katsuyama

6

1 reference

20 September 2017

Fuminori Hyodoh

7

1 reference

20 September 2017

Wataru Fujimoto

8

1 reference

20 September 2017

Hiroaki Ueki

9

1 reference

20 September 2017

Masayasu Kusaka

10

1 reference

20 September 2017

Hisashi Arikuni

11

1 reference

20 September 2017

Takemi Otsuki

12

1 reference

20 September 2017

publication date

1 September 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

116

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

21-29

1 reference

Antidesmoglein autoantibodies in silicosis patients with no bullous diseases

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

The use of seldi proteinchip arrays to monitor production of Alzheimer's betaamyloid in transfected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

Human myeloma cell apoptosis induced by interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

Identification of amino acid residues important for ligand binding to Fas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

Characterization of Fas (Apo-1, CD95)-Fas ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

A novel domain within the 55 kd TNF receptor signals cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

The three-dimensional solution structure and dynamic properties of the human FADD death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

Detection of anti-topoisomerase I autoantibody in patients with silicosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802403

Cellular biological differences between human myeloma cell lines KMS-12-PE and KMS-12-BM established from a single patient.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802403

Estrogen receptors in human myeloma cells

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802403

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802403

Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802403

Mapping of the linear site on the Fas/APO-1 molecule targeted by the prototypic anti-Fas mAb.

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802403

A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802403

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802403

The 1982 revised criteria for the classification of systemic lupus erythematosus

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802403

Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).

29 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802403

Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support

29 August 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02192.X

Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects

21 January 2018

1 reference

12 December 2020

Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro

1 reference

12 December 2020

Soluble Fas mRNA is dominantly expressed in cases with silicosis

1 reference

12 December 2020

Requirement of cysteine-rich repeats of the Fas receptor for binding by the Fas ligand

1 reference

12 December 2020

Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours

1 reference

12 December 2020

A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites

1 reference

12 December 2020

10.1111/J.1365-2567.2005.02192.X

Identifiers

DOI

1 reference

20 September 2017

0 references

1 reference